The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Endocrine-Related Cancer

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1677/ERC-07-0226PMID 18310298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The non-genomic crosstalk between PPAR-γ ligands and ERK1/2 in cancer cell lines

  2007cited by this paper
• Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System

  2007cited by this paper
• Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

  2007cited by this paper
• MAPK- Kinases as Nucleo-Cytoplasmic Shuttles for PPARγ

  2007cited by this paper
• Effects of Thiazolidinediones on Differentiation, Proliferation, and Apoptosis

  2007cited by this paper
• Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP.

  2007cited by this paper
• The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines.

  2007cited by this paper
• Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer.

  2006cited by this paper
• PPAR-γ ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells

  2006cited by this paper
• Investigational PPAR-γ agonists for the treatment of Type 2 diabetes

  2006cited by this paper
• PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells.

  2006cited by this paper
• Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.

  2005cited by this paper
• Antineoplastic effects of peroxisome proliferator activated receptorγ agonists

  2005cited by this paper
• Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice

  2005cited by this paper
• Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?

  2005cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1.

  2005cited by this paper
• Gene-nutrient interactions during fetal development.

  2005cited by this paper
• Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes.

  2005cited by this paper
• Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.

  2004cited by this paper
• Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.

  2004cited by this paper
• Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists

  2004cited by this paper
• Nutritional modulation of the cell cycle and breast cancer.

  2004cited by this paper
• A Nucleoprotein Complex Containing Sp1, C/EBPβ, and HMGI-Y Controls Human Insulin Receptor Gene Transcription

  2003cited by this paper
• Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-&dgr; and Peroxisome Proliferator-Activated Receptor-&ggr;

  2002cited by this paper
• The mechanisms of action of PPARs.

  2002cited by this paper
• Small Heterodimer Partner, an Orphan Nuclear Receptor, Augments Peroxisome Proliferator-activated Receptor γ Transactivation*

  2002influential reference
• Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.

  2002cited by this paper
• Transcription Suppression of Thromboxane Receptor Gene by Peroxisome Proliferator-activated Receptor-γ via an Interaction with Sp1 in Vascular Smooth Muscle Cells*

  2002cited by this paper
• Inhibitory Effects of Peroxisome Proliferator-Activated Receptor γ on Thyroid Carcinoma Cell Growth

  2002cited by this paper
• Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-δ and Peroxisome Proliferator-Activated Receptor-γ

  2002cited by this paper
• Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.

  2001cited by this paper
• Peroxisome proliferator-activated receptors: from genes to physiology.

  2001cited by this paper
• Transcriptional regulation of human insulin receptor gene by the high‐mobility group protein HMGI(Y)

  2001cited by this paper
• Inhibition of Cellular Proliferation through IκB Kinase-Independent and Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of Cyclin D1

  2001cited by this paper
• Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

  2001cited by this paper
• Roles of PPARs in health and disease

  2000cited by this paper
• PPAR-gamma-mediated regulation of normal and malignant B lineage cells.

  2000cited by this paper
• PPAR‐γ‐Mediated Regulation of Normal and Malignant B Lineage Cells

  2000cited by this paper
• PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

  1999cited by this paper
• Peroxisome proliferator-activated receptors: nuclear control of metabolism.

  1999cited by this paper
• PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.

  1999cited by this paper
• PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development

  1999cited by this paper
• PPAR gamma is required for placental, cardiac, and adipose tissue development.

  1999cited by this paper
• Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

  1998cited by this paper
• Terminal differentiation of human breast cancer through PPAR gamma.

  1998cited by this paper
• Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.

  1997cited by this paper
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

  1996cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 in the transcriptional regulation of the acyl-coenzyme-A oxidase promoter.

  1995cited by this paper
• An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)

  1995cited by this paper
• Molecular basis of thyroid cancer.

  1994cited by this paper
• Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

  1994cited by this paper
• The insulin signaling system.

  1994cited by this paper
• Molecular basis of thyroid cancer.

  1994cited by this paper
• Peroxisome Proliferator‐Activated Receptors and Lipid Metabolism a

  1993cited by this paper
• Identification of unique nuclear regulatory proteins for the insulin receptor gene, which appear during myocyte and adipocyte differentiation.

  1993cited by this paper
• Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.

  1993cited by this paper
• Insulin receptor expression and function in human breast cancer cell lines.

  1992cited by this paper
• Regulating Insulin-Receptor-Gene Expression by Differentiation and Hormones

  1990cited by this paper
• Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels.

  1989cited by this paper
• Characterization of the promoter region of the human insulin receptor gene.

  1989cited by this paper
• Structure of the human insulin receptor gene and characterization of its promoter.

  1989cited by this paper
• Characterization of the promoter region of the human insulin receptor gene. Evidence for promoter activity.

  1987cited by this paper
• The insulin receptor: molecular biology and transmembrane signaling.

  1987cited by this paper
• Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes

  1985cited by this paper
• Correlation among insulin binding, degradation, and biological activity in human breast cancer cells in long-term tissue culture.

  1978cited by this paper

• Disease-specific epigenetic deregulation of enhancers, transposons, and polycomb targets in acute promyelocytic leukemia

  2025cites this paper
• Activation of Genes by Nuclear Receptor/Specificity Protein (Sp) Interactions in Cancer

  2025cites this paper
• Diabetes Driven Oncogenesis and Anticancer Potential of Repurposed Antidiabetic Drug: A Systemic Review

  2024cites this paper
• Association of epilepsy, anti-epileptic drugs (AEDs), and type 2 diabetes mellitus (T2DM): a population-based cohort retrospective study, impact of AEDs on T2DM-related molecular pathway, and via peroxisome proliferator-activated receptor γ transactivation

  2023cites this paper
• Chemical Mixtures in Household Environments: In Silico Predictions and In Vitro Testing of Potential Joint Action on PPARγ in Human Liver Cells

  2022cites this paper
• Inhibition of miR-128-3p Attenuated Doxorubicin-Triggered Acute Cardiac Injury in Mice by the Regulation of PPAR-γ

  2021cites this paper
• Adipose Tissue—Breast Cancer Crosstalk Leads to Increased Tumor Lipogenesis Associated with Enhanced Tumor Growth

  2021cites this paper
• Insulin Resistance and Cancer: In Search for a Causal Link

  2021cites this paper
• Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects

  2021cites this paper
• Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases

  2020cites this paper
• The Role of PPARδ Agosnist GW501516 in Rats with Gestational Diabetes Mellitus

  2020cites this paper
• Synthesis, Anticancer and Antibacterial Studies of Benzylidene Bearing 5-substituted and 3,5-disubstituted-2,4-Thiazolidinedione Derivatives.

  2020cites this paper
• Synthesis, In Vitro Anticancer, Anti-Inflammatory and DNA Binding Activity of Thiazolidinedione Derivatives.

  2020cites this paper
• An insight into the synthesis and SAR of 2,4-thiazolidinediones (2,4-TZD) as multifunctional scaffold: A review.

  2020cites this paper
• NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells

  2019cites this paper
• Alizarin increase glucose uptake through PI3K/Akt signaling and improve alloxan-induced diabetic mice.

  2019cites this paper
• Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation

  2019cites this paper
• Editorial: Hormone Receptors and Breast Cancer

  2019cites this paper
• Arsenic Trioxide in Synergy with Vitamin D Rescues the Defective VDR-PPAR-γ Functional Module of Autophagy in Rheumatoid Arthritis

  2019cites this paper
• Cell-line characterization by infrared-induced pyroelectric effect.

  2019cites this paper
• Oleacein Prevents High Fat Diet-Induced Adiposity and Ameliorates Some Biochemical Parameters of Insulin Sensitivity in Mice

  2019cites this paper
• PPAR-γ Ligand Inhibits Nasopharyngeal Carcinoma Cell Proliferation and Metastasis by Regulating E2F2

  2019cites this paper
• Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Non-alcoholic Fatty Liver Disease

  2019cites this paper
• PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling.

  2019cites this paper
• Transcriptional Regulation of INSR, the Insulin Receptor Gene

  2019cites this paper
• Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor

  2018cites this paper
• Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators

  2018cites this paper
• PPARγ Antagonizes Hypoxia-Induced Activation of Hepatic Stellate Cell through Cross Mediating PI3K/AKT and cGMP/PKG Signaling

  2018cites this paper
• HMGA1 Mediated High-Glucose-Induced Vascular Smooth Muscle Cell Proliferation in Diabetes Mellitus: Association Between PI3K/Akt Signaling and HMGA1 Expression

  2018cites this paper
• High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.

  2018cites this paper
• Pyroelectric Sensor for Characterization of Biological Cells

  2018cites this paper
• Secretome Analysis of Hypoxia‐Induced 3T3‐L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity

  2018cites this paper
• Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice

  2018cites this paper
• The Destiny of Glucose from a MicroRNA Perspective

  2018cites this paper
• HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.

  2018cites this paper
• Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links

  2018cites this paper
• The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells

  2018cites this paper
• Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling

  2018cites this paper
• Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance

  2017cites this paper
• Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study

  2017cites this paper
• HMGA1 is a novel transcriptional regulator of the FoxO1 gene

  2017cites this paper
• IR-Light induced pyroelectric effect for cell cultures characterization

  2017cites this paper
• Insulin and osteocalcin: further evidence for a mutual cross-talk

  2017cites this paper
• Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk.

  2016cites this paper
• Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPβ and PPARγ mediated lipoapoptosis

  2015cites this paper
• Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events

  2014cites this paper
• Social isolation stress, obesity, and breast cancer risk in mice

  2014cites this paper
• Transcriptional Regulation of the HMGA1 Gene by Octamer-Binding Proteins Oct-1 and Oct-2

  2013cites this paper
• PPAR GAMMA AGONISTS: AN EFFECTIVE STRATEGY FOR CANCER TREATMENT

  2013cites this paper
• A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors

  2013cites this paper
• Diabetes and Cancer: Epidemiological, Clinical, and Experimental Perspectives

  2012cites this paper
• Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms

  2012cites this paper
• The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis

  2009cites this paper
• Fish Oil Inhibits Human Lung Carcinoma Cell Growth by Suppressing Integrin-Linked Kinase

  2009cites this paper
• Obesity and Breast Cancer: The Roles of Peroxisome Proliferator-Activated Receptor-γ and Plasminogen Activator Inhibitor-1

  2009cites this paper
• New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor

  2009cites this paper